Atherosclerotic cardiovascular disease (CVD), including myocardial infarction and stroke, is the leading cause of death worldwide. Major risk factors for CVD include dyslipoproteinemia, smoking, hypertension, obesity, and diabetes. However, despite optimal pharmacological treatment of these risk factors, a considerable residual CVD risk remains. Evidence is rapidly accumulating that chronic low-grade inflammation of the vascular wall is a key pathophysiological component of atherosclerosis, and that treatment with anti-inflammatory drugs, such as canakinumab and colchicine, additionally lowers future CVD risk (Nidorf et al., 2020; Ridker et al., 2017; Tardif et al., 2019). More detailed knowledge of this inflammatory process and the role of individual immune cells would allow the development of more specific and safe anti-inflammatory therapies.

Within atherosclerotic plaques, monocyte-derived macrophages are the most abundant immune cells, which play a key role in initiation, progression, and destabilization of these plaques, although the mechanisms driving the persistent inflammatory activation are poorly understood (Moore et al., 2013). In patients with CVD or risk factors for CVD, circulating leukocytes show differences in composition and individual cell phenotypes, compared to healthy individuals. Isolated monocytes from patients with CVD are characterized by an increased cytokine production capacity and higher glycolytic metabolism (Bekkering et al., 2016; Elsenberg et al., 2013; Shirai et al., 2016). This also holds true for patients with increased CVD risk due to familial hypercholesterolemia (Bekkering et al., 2019). In addition, higher circulating levels of granulocytes are associated with an increased CVD risk in a general population study (Fani et al., 2020).

Experimental studies in animal models of atherosclerosis have revealed reprogramming of hematopoietic stem and progenitor cells (HSPCs) in the bone marrow as a cause of these changes in circulating innate immune cells under conditions that predispose to CVD, including hyperlipidemia (Christ et al., 2018), and stress (Heidt et al., 2014). Western-type diet feeding of low-density lipoprotein receptor deficient (Ldlr-/-) mice induces inflammatory activation of monocytes by epigenetic reprogramming of HSPCs which persists in normocholesterolemic conditions (Christ et al., 2018). This resembles the finding of persistent functional and transcriptional hyperresponsive monocytes in patients with dyslipidemia despite cholesterol-lowering treatment (Bekkering et al., 2019). In a retrospective analysis of bone marrow samples from cancer patients, HSPCs had a higher proliferative potential in patients with known atherosclerotic CVD than in control patients (van der Valk et al., 2016). A detailed assessment, however, of HSPC composition and function in patients with atherosclerosis is lacking.

Here we performed a comprehensive study in patients with and without coronary artery disease (CAD). We obtained circulating leukocytes and HSPCs and assessed composition with flow cytometry, as well as cytokine production capacity, metabolism, and the transcriptional profile. In addition, we performed 2’-deoxy-2’-[¹⁸F]fluoro-D-glucose positron-emission-tomography ([¹⁸F]FDG PET/CT) scanning to detect bone marrow and splenic activity. We report that bone marrow mononuclear cells in patients with atherosclerosis are characterized by enhanced cytokine production capacity and an increased metabolic rate. Flow cytometry and RNAseq analysis revealed inflammatory transcriptional reprogramming and myeloid skewing. These results show that in patients with atherosclerosis, activation of the innate immune system occurs at the level of bone marrow myeloid progenitors, which adds exciting opportunities for novel treatment strategies.

The role of activated innate immune cells in the development of atherosclerotic plaques is well-established. In the current paper we add an important dimension to this pathophysiological framework by showing for the first time that inflammatory reprogramming of innate immune cells in humans with coronary artery disease occurs at the level of HSPCs in the bone marrow. In patients with chronic CAD due to severe coronary atherosclerosis, isolated bone marrow mononuclear cells showed a higher cytokine production capacity and increased metabolic rate compared to individuals without coronary atherosclerosis. Transcriptional signatures of HSPCs were enriched for neutrophil and monocyte related pathways, indicating that the HSPCs are primed to differentiate into an inflammatory myeloid lineage. These findings addinclude an additional layer of inflammatory regulation in atherogenesis which potentially offers novel targets for pharmacological strategies to prevent or treat atherosclerotic CVD.

Our findings align with previous studies in animal models in atherosclerosis that show increased myelopoiesis in specific conditions that promote CVD. Accumulation of cholesterol in HSPC increases proliferation and mobilization from the bone marrow and a differentiation bias towards the myeloid lineage, which is associated with accelerated atherosclerosis (Yvan-Charvet et al., 2010). In an animal model of diabetes, higher circulating numbers of inflammatory Ly6-C^hi monocytes and neutrophils are present, which is due to increased myelopoiesis. In this model, the increased myelopoiesis is driven by the increased expression of S100A8 and S100A9 in neutrophils (Nagareddy et al., 2013). Interestingly, the expression of one of the S100 proteins (S100A11) was also increased in the HSCs in patients with CAD in our study. Chronic psychological stress and disturbed sleep have also been reported to increase myelopoiesis, which is associated with elevated circulating levels of neutrophils and Ly6C^high monocytes and augmented atherosclerosis compared with control mice (Heidt et al., 2014; McAlpine et al., 2019).

Since we did not include patients with specific cardiovascular risk factors, but rather with established symptomatic coronary atherosclerosis, we cannot conclude which factors are responsible for the HSPC reprogramming in our patients. BMI and blood pressure were slightly higher in the patients compared to the controls. Cholesterol concentrations were lower at the moment of inclusion in our study, but might well have been higher previously, since the patients also used more statins. We do not have information about stress and sleep patterns. Another mechanism that might contribute to the HSPC functional reprogramming is trained immunity. Trained immunity describes the phenomenon that brief stimulation of innate immune cells leads to the development of a long-term hyperresponsive phenotype. This is mediated by profound intracellular metabolic and epigenetic reprogramming and occurs both at the level of mature circulating monocytes as well as at the level of their bone marrow progenitors (Netea et al., 2020). Christ et al have recently described that a 4-week period of Western-type diet feeding in atherosclerosis prone Ldlr-/-mice induced a functional, transcriptional and epigenetic reprogramming of circulating myeloid cells and their bone marrow progenitors, which persisted for at least for weeks after switching back to a chow diet (Christ et al., 2018). This was associated with increased circulating concentrations of inflammatory monocytes and granulocytes. Functional enrichment analysis of GMPs showed overrepresentation of TNF and Toll-like receptor signaling pathways, which align with our observations. In contrast, although monocytic signature genes were enriched, most of the granulocytic signature genes were downregulated, including S100A8 and S100A9, in GMPs isolated from WD-fed as compared to CD-fed mice (Christ et al., 2018). Patients with hypercholesterolemia also have circulating monocytes with augmented cytokine production capacity, increased glycolytic metabolism, and enrichment of activating histone modifications, which persist for three months despite cholesterol lowering with statin therapy. Circulating monocyte and neutrophil numbers, however, were not increased in these patients (Bekkering et al., 2019). In our current patient cohort, it remains to be established whether trained immunity is present since we did not assess epigenetic markers in the HSPCs.

The observation that absolute numbers of myeloid progenitors and circulating monocytes and neutrophils are not increased, despite functional and transcriptional inflammatory programming, fits with the effects of alternative inducers of trained immunity in humans. Vaccination with the Bacille Calmette-Guérin (BCG) vaccine induces trained immunity in humans in vivo (Arts et al., 2018). This is accompanied by an increased cytokine production capacity of bone marrow mononuclear cells, comparable to the result in patients with CAD in the current study (Cirovic et al., 2020). Also, 90 days post-BCG administration, HSPCs showed myeloid skewing with activation of neutrophil-associated pathways and pathways associated with regulation of immune responses, comparable to our patients. This functional and transcriptional reprogramming was accompanied by an increase in numbers of circulating myeloid cells in large cohorts of infants vaccinated with BCG (Cirovic et al., 2020).

In the patient group with CAD, the increased cytokine production capacity of the bone marrow mononuclear cell fraction was accompanied by an upregulation of both glycolytic metabolism as well as oxygen consumption by oxidative phosphorylation. It is important to realize that the bone marrow mononuclear fraction also contains large amounts of mature monocytes, so we cannot conclude on the metabolic landscape of HSPCs and specific progenitor subtypes. Isolated monocytes and monocyte-derived macrophages from patients with atherosclerosis are characterized by increased glycolysis, which is coupled to the hyperresponsiveness in terms of cytokine release (Bekkering et al., 2016; Shirai et al., 2016). Also, HSPCs of mice after induction of trained immunity with β-glucan have an upregulation of the glycolytic pathway (Mitroulis et al., 2018).

Analysis of the differentially upregulated genes transcriptome of the flow-sorted HSCs and GMPs showed significant enrichment for neutrophil activation pathways. This further supports a role for neutrophils in the pathophysiology of atherosclerotic CVD, which is suggested by various recent findings in the literature. Although neutrophils are the most abundant circulating white blood cell type, neutrophils only recently received attention in the context of cardiovascular inflammation. A large epidemiological study shows that circulating granulocyte counts are strongly associated with the occurrence of CVD (Fani et al., 2020). During atherogenesis, platelet-derived chemokines, such as CC-chemokine ligand 5, promote neutrophil activation and recruitment (Silvestre-Roig et al., 2020). At the luminal side, these activated neutrophils secrete granule proteins, including cathepsin G, which further promotes myeloid cell recruitment. Several actions further fuel atherosclerotic plaque formation, including secretion of reactive oxygen species and myeloperoxidase, which mediates oxidation of LDL, promoting foam cell formation (Silvestre-Roig et al., 2020). Also, neutrophils can form neutrophil extracellular traps (NETs) (Döring et al., 2020) and they can secrete pro-inflammatory microvesicles, which further fuel vascular wall inflammation and atherosclerosis (Gomez et al., 2020). Interestingly, a recent study used plasma proteomics analysis to explore the mechanism by which colchicine lowers cardiovascular risk in patients with CAD and showed mainly a downregulation of neutrophil activation pathways (Opstal et al., 2020).

Analysis of the individual significantly differentially expressed genes in the HSPCs showed that the glycolytic enzyme phosphofructokinase (PFKP) was downregulated in patients with CAD. Quiescent HSCs depend mainly on anaerobic glycolysis to sustain survival, quiescence, and retention within the bone marrow (Takubo et al., 2010). Once stimulated to divide, HSCs start to activate OXPHOS to meet metabolic demands of proliferation and differentiation (Karigane and Takubo, 2017). Therefore, the downregulation of PFKP might be related to the activation of HSCs. This finding is in contrast to the higher extracellular acidification rate of the bone marrow mononuclear cells which points to the activation of glycolysis. We speculate that this finding is dominated by the inflammatory activation of bone marrow monocytes, which constitute a large percentage of the bone marrow mononuclear cells. The chemokine receptor CCR2 showed significant upregulation in the HSPCs of the patients with CAD. CCR2 is critical for monocyte egress from the bone marrow and for the recruitment of circulating monocytes to the arterial wall (Tsou et al., 2007). The upregulation of CCR2 in our study might contribute to the increased circulating HSC percentage in patients with CAD. In mice, increased levels of circulating HSPCs are found after myocardial infarction that migrate to the spleen for extramedullary hematopoiesis (Dutta et al., 2012). In humans, splenic extramedullary hematopoiesis can occur in response to extreme physiologic stress (e.g. sepsis or hematologic malignancies), but has not been described yet during the development of CVD. Indirect evidence shows that splenic activity in humans is increased after myocardial infarction assessed with PET/CT scanning (van der Valk et al., 2016), suggesting increased immune cell activation. In our study, we observed a correlation between splenic activity and CCR2 expression on circulating HSPCs which might suggest that the spleen performs a role in human atherosclerosis.

Our study has several limitations. First, the sample size is relatively small. However, this sample size needs to be considered in the context of the invasive and complex nature of the study, and this sample size usually allows to detect relevant differences (Cirovic et al., 2020; van der Heijden et al., 2020). The sample size might also be an explanation for the lack of a significant difference in FDG uptake in the large arteries, which has been shown previously in patients with CVD. (Tarkin et al., 2014; van Wijk et al., 2014). Another possible explanation for our results is that our patients had severe mature coronary atherosclerotic plaques with calcium deposits, which are known to have less FDG uptake than uncalcified arterial plaques at the early stage of atherosclerosis (Fernández-Friera et al., 2019). In addition, lipid-lowering therapy is effective in reducing vascular wall inflammation (Pirro et al., 2019). Second, we did not explore epigenetic programs of the HSPCs. As such, we cannot conclude whether the mechanism of trained immunity contributes to our findings. This should be the focus of future studies. Third, in a study on symptomatic patients with CVD, it is inevitable to have differences in medication use compared to the healthy control group.

To summarize, our study is the first to prospectively assess HSPC phenotype in patients with CAD and is unique in providing a comprehensive phenotype by the integration of powerful tools such as RNAseq on flow-sorted HSPC populations, functional parameters, Seahorse respiratory, and PET imaging of vascular wall and hematopoietic activity. These results show that in patients with CAD, activation of the innate immune system occurs at the level of bone marrow myeloid progenitors, which adds exciting opportunities for novel treatment strategies.

RNA-seq data have been deposited in the ArrayExpress database at EMBL-EBI (https://www.ebi.ac.uk/arrayexpress) under accession number E-MTAB-9399.

1. 1. Noz M
   2. Bekkering S
   3. Riksen NP
   4. Netea MG

   (2020) ArrayExpress

   ID E-MTAB-9399. Bone marrow progenitor cell populations of patients with severe coronary artery disease.

   https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-9399/

1. 1. Arts RJW
   2. Moorlag S
   3. Novakovic B
   4. Li Y
   5. Wang SY
   6. Oosting M
   7. Kumar V
   8. Xavier RJ
   9. Wijmenga C
   10. Joosten LAB
   11. Reusken C
   12. Benn CS
   13. Aaby P
   14. Koopmans MP
   15. Stunnenberg HG
   16. van Crevel R
   17. Netea MG

   (2018) BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity

   Cell Host & Microbe 23:89–100.

   https://doi.org/10.1016/j.chom.2017.12.010

   • PubMed
   • Google Scholar
2. 1. Ashburner M
   2. Ball CA
   3. Blake JA
   4. Botstein D
   5. Butler H
   6. Cherry JM
   7. Davis AP
   8. Dolinski K
   9. Dwight SS
   10. Eppig JT
   11. Harris MA
   12. Hill DP
   13. Issel-Tarver L
   14. Kasarskis A
   15. Lewis S
   16. Matese JC
   17. Richardson JE
   18. Ringwald M
   19. Rubin GM
   20. Sherlock G

   (2000) Gene ontology: tool for the unification of biology the gene ontology consortium

   Nature Genetics 25:25–29.

   https://doi.org/10.1038/75556

   • PubMed
   • Google Scholar
3. 1. Bekkering S
   2. van den Munckhof I
   3. Nielen T
   4. Lamfers E
   5. Dinarello C
   6. Rutten J
   7. de Graaf J
   8. Joosten LA
   9. Netea MG
   10. Gomes ME
   11. Riksen NP

   (2016) Innate immune cell activation and epigenetic remodeling in symptomatic and asymptomatic atherosclerosis in humans in vivo

   Atherosclerosis 254:228–236.

   https://doi.org/10.1016/j.atherosclerosis.2016.10.019

   • PubMed
   • Google Scholar
4. 1. Bekkering S
   2. Stiekema LCA
   3. Bernelot Moens S
   4. Verweij SL
   5. Novakovic B
   6. Prange K
   7. Versloot M
   8. Roeters van Lennep JE
   9. Stunnenberg H
   10. de Winther M
   11. Stroes ESG
   12. Joosten LAB
   13. Netea MG
   14. Riksen NP

   (2019) Treatment with statins does not revert trained immunity in patients with familial hypercholesterolemia

   Cell Metabolism 30:1–2.

   https://doi.org/10.1016/j.cmet.2019.05.014

   • PubMed
   • Google Scholar
5. 1. Bucerius J
   2. Hyafil F
   3. Verberne HJ
   4. Slart RH
   5. Lindner O
   6. Sciagra R
   7. Agostini D
   8. Übleis C
   9. Gimelli A
   10. Hacker M
   11. Cardiovascular Committee of the European Association of Nuclear Medicine (EANM)

   (2016) Position paper of the cardiovascular committee of the european association of nuclear medicine (EANM) on PET imaging of atherosclerosis

   European Journal of Nuclear Medicine and Molecular Imaging 43:780–792.

   https://doi.org/10.1007/s00259-015-3259-3

   • PubMed
   • Google Scholar
6. 1. Christ A
   2. Günther P
   3. Lauterbach MAR
   4. Duewell P
   5. Biswas D
   6. Pelka K
   7. Scholz CJ
   8. Oosting M
   9. Haendler K
   10. Baßler K
   11. Klee K
   12. Schulte-Schrepping J
   13. Ulas T
   14. Moorlag S
   15. Kumar V
   16. Park MH
   17. Joosten LAB
   18. Groh LA
   19. Riksen NP
   20. Espevik T
   21. Schlitzer A
   22. Li Y
   23. Fitzgerald ML
   24. Netea MG
   25. Schultze JL
   26. Latz E

   (2018) Western diet triggers NLRP3-Dependent innate immune reprogramming

   Cell 172:162–175.

   https://doi.org/10.1016/j.cell.2017.12.013

   • Google Scholar
7. 1. Cirovic B
   2. de Bree LCJ
   3. Groh L
   4. Blok BA
   5. Chan J
   6. van der Velden WJFM
   7. Bremmers MEJ
   8. van Crevel R
   9. Händler K
   10. Picelli S
   11. Schulte-Schrepping J
   12. Klee K
   13. Oosting M
   14. Koeken VACM
   15. van Ingen J
   16. Li Y
   17. Benn CS
   18. Schultze JL
   19. Joosten LAB
   20. Curtis N
   21. Netea MG
   22. Schlitzer A

   (2020) BCG vaccination in humans elicits trained immunity via the hematopoietic progenitor compartment

   Cell Host & Microbe 28:322–334.

   https://doi.org/10.1016/j.chom.2020.05.014

   • Google Scholar
8. 1. Döring Y
   2. Libby P
   3. Soehnlein O

   (2020) Neutrophil extracellular traps participate in cardiovascular diseases: recent experimental and clinical insights

   Circulation Research 126:1228–1241.

   https://doi.org/10.1161/CIRCRESAHA.120.315931

   • PubMed
   • Google Scholar
9. 1. Dutta P
   2. Courties G
   3. Wei Y
   4. Leuschner F
   5. Gorbatov R
   6. Robbins CS
   7. Iwamoto Y
   8. Thompson B
   9. Carlson AL
   10. Heidt T
   11. Majmudar MD
   12. Lasitschka F
   13. Etzrodt M
   14. Waterman P
   15. Waring MT
   16. Chicoine AT
   17. van der Laan AM
   18. Niessen HW
   19. Piek JJ
   20. Rubin BB
   21. Butany J
   22. Stone JR
   23. Katus HA
   24. Murphy SA
   25. Morrow DA
   26. Sabatine MS
   27. Vinegoni C
   28. Moskowitz MA
   29. Pittet MJ
   30. Libby P
   31. Lin CP
   32. Swirski FK
   33. Weissleder R
   34. Nahrendorf M

   (2012) Myocardial infarction accelerates atherosclerosis

   Nature 487:325–329.

   https://doi.org/10.1038/nature11260

   • PubMed
   • Google Scholar
10. 1. Elsenberg EH
    2. Sels JE
    3. Hillaert MA
    4. Schoneveld AH
    5. van den Dungen NA
    6. van Holten TC
    7. Roest M
    8. Jukema JW
    9. van Zonneveld AJ
    10. de Groot PG
    11. Pijls N
    12. Pasterkamp G
    13. Hoefer IE

    (2013) Increased cytokine response after toll-like receptor stimulation in patients with stable coronary artery disease

    Atherosclerosis 231:346–351.

    https://doi.org/10.1016/j.atherosclerosis.2013.09.036

    • PubMed
    • Google Scholar
11. 1. Ewels P
    2. Magnusson M
    3. Lundin S
    4. Käller M

    (2016) MultiQC: summarize analysis results for multiple tools and samples in a single report

    Bioinformatics 32:3047–3048.

    https://doi.org/10.1093/bioinformatics/btw354

    • PubMed
    • Google Scholar
12. 1. Fani L
    2. van der Willik KD
    3. Bos D
    4. Leening MJG
    5. Koudstaal PJ
    6. Rizopoulos D
    7. Ruiter R
    8. Stricker BHC
    9. Kavousi M
    10. Ikram MA
    11. Ikram MK

    (2020) The association of innate and adaptive immunity, subclinical atherosclerosis, and cardiovascular disease in the rotterdam study: a prospective cohort study

    PLOS Medicine 17:e1003115.

    https://doi.org/10.1371/journal.pmed.1003115

    • PubMed
    • Google Scholar
13. 1. Fernández-Friera L
    2. Fuster V
    3. López-Melgar B
    4. Oliva B
    5. Sánchez-González J
    6. Macías A
    7. Pérez-Asenjo B
    8. Zamudio D
    9. Alonso-Farto JC
    10. España S
    11. Mendiguren J
    12. Bueno H
    13. García-Ruiz JM
    14. Ibañez B
    15. Fernández-Ortiz A
    16. Sanz J

    (2019) Vascular inflammation in subclinical atherosclerosis detected by hybrid PET/MRI

    Journal of the American College of Cardiology 73:1371–1382.

    https://doi.org/10.1016/j.jacc.2018.12.075

    • PubMed
    • Google Scholar
14. 1. Gomez I
    2. Ward B
    3. Souilhol C
    4. Recarti C
    5. Ariaans M
    6. Johnston J
    7. Burnett A
    8. Mahmoud M
    9. Luong LA
    10. West L
    11. Long M
    12. Parry S
    13. Woods R
    14. Hulston C
    15. Benedikter B
    16. Niespolo C
    17. Bazaz R
    18. Francis S
    19. Kiss-Toth E
    20. van Zandvoort M
    21. Schober A
    22. Hellewell P
    23. Evans PC
    24. Ridger V

    (2020) Neutrophil microvesicles drive atherosclerosis by delivering miR-155 to atheroprone endothelium

    Nature Communications 11:214.

    https://doi.org/10.1038/s41467-019-14043-y

    • PubMed
    • Google Scholar
15. 1. Hashimshony T
    2. Wagner F
    3. Sher N
    4. Yanai I

    (2012) CEL-Seq: single-cell RNA-Seq by multiplexed linear amplification

    Cell Reports 2:666–673.

    https://doi.org/10.1016/j.celrep.2012.08.003

    • PubMed
    • Google Scholar
16. 1. Heidt T
    2. Sager HB
    3. Courties G
    4. Dutta P
    5. Iwamoto Y
    6. Zaltsman A
    7. von Zur Muhlen C
    8. Bode C
    9. Fricchione GL
    10. Denninger J
    11. Lin CP
    12. Vinegoni C
    13. Libby P
    14. Swirski FK
    15. Weissleder R
    16. Nahrendorf M

    (2014) Chronic variable stress activates hematopoietic stem cells

    Nature Medicine 20:754–758.

    https://doi.org/10.1038/nm.3589

    • PubMed
    • Google Scholar
17. 1. Karigane D
    2. Takubo K

    (2017) Metabolic regulation of hematopoietic and leukemic stem/progenitor cells under homeostatic and stress conditions

    International Journal of Hematology 106:18–26.

    https://doi.org/10.1007/s12185-017-2261-x

    • PubMed
    • Google Scholar
18. 1. Li H
    2. Durbin R

    (2010) Fast and accurate long-read alignment with Burrows-Wheeler transform

    Bioinformatics 26:589–595.

    https://doi.org/10.1093/bioinformatics/btp698

    • PubMed
    • Google Scholar
19. 1. Love MI
    2. Huber W
    3. Anders S

    (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

    Genome Biology 15:550.

    https://doi.org/10.1186/s13059-014-0550-8

    • PubMed
    • Google Scholar
20. 1. McAlpine CS
    2. Kiss MG
    3. Rattik S
    4. He S
    5. Vassalli A
    6. Valet C
    7. Anzai A
    8. Chan CT
    9. Mindur JE
    10. Kahles F
    11. Poller WC
    12. Frodermann V
    13. Fenn AM
    14. Gregory AF
    15. Halle L
    16. Iwamoto Y
    17. Hoyer FF
    18. Binder CJ
    19. Libby P
    20. Tafti M
    21. Scammell TE
    22. Nahrendorf M
    23. Swirski FK

    (2019) Sleep modulates haematopoiesis and protects against atherosclerosis

    Nature 566:383–387.

    https://doi.org/10.1038/s41586-019-0948-2

    • PubMed
    • Google Scholar
21. 1. Mitroulis I
    2. Ruppova K
    3. Wang B
    4. Chen LS
    5. Grzybek M
    6. Grinenko T
    7. Eugster A
    8. Troullinaki M
    9. Palladini A
    10. Kourtzelis I
    11. Chatzigeorgiou A
    12. Schlitzer A
    13. Beyer M
    14. Joosten LAB
    15. Isermann B
    16. Lesche M
    17. Petzold A
    18. Simons K
    19. Henry I
    20. Dahl A
    21. Schultze JL
    22. Wielockx B
    23. Zamboni N
    24. Mirtschink P
    25. Coskun Ü
    26. Hajishengallis G
    27. Netea MG
    28. Chavakis T

    (2018) Modulation of myelopoiesis progenitors is an integral component of trained immunity

    Cell 172:147–161.

    https://doi.org/10.1016/j.cell.2017.11.034

    • PubMed
    • Google Scholar
22. 1. Moore KJ
    2. Sheedy FJ
    3. Fisher EA

    (2013) Macrophages in atherosclerosis: a dynamic balance

    Nature Reviews Immunology 13:709–721.

    https://doi.org/10.1038/nri3520

    • PubMed
    • Google Scholar
23. 1. Nagareddy PR
    2. Murphy AJ
    3. Stirzaker RA
    4. Hu Y
    5. Yu S
    6. Miller RG
    7. Ramkhelawon B
    8. Distel E
    9. Westerterp M
    10. Huang LS
    11. Schmidt AM
    12. Orchard TJ
    13. Fisher EA
    14. Tall AR
    15. Goldberg IJ

    (2013) Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis

    Cell Metabolism 17:695–708.

    https://doi.org/10.1016/j.cmet.2013.04.001

    • PubMed
    • Google Scholar
24. 1. Netea MG
    2. Domínguez-Andrés J
    3. Barreiro LB
    4. Chavakis T
    5. Divangahi M
    6. Fuchs E
    7. Joosten LAB
    8. van der Meer JWM
    9. Mhlanga MM
    10. Mulder WJM
    11. Riksen NP
    12. Schlitzer A
    13. Schultze JL
    14. Stabell Benn C
    15. Sun JC
    16. Xavier RJ
    17. Latz E

    (2020) Defining trained immunity and its role in health and disease

    Nature Reviews Immunology 20:375–388.

    https://doi.org/10.1038/s41577-020-0285-6

    • PubMed
    • Google Scholar
25. 1. Nidorf SM
    2. Fiolet ATL
    3. Mosterd A
    4. Eikelboom JW
    5. Schut A
    6. Opstal TSJ
    7. The SHK
    8. Xu X-F
    9. Ireland MA
    10. Lenderink T
    11. Latchem D
    12. Hoogslag P
    13. Jerzewski A
    14. Nierop P
    15. Whelan A
    16. Hendriks R
    17. Swart H
    18. Schaap J
    19. Kuijper AFM
    20. van Hessen MWJ
    21. Saklani P
    22. Tan I
    23. Thompson AG
    24. Morton A
    25. Judkins C
    26. Bax WA
    27. Dirksen M
    28. Alings M
    29. Hankey GJ
    30. Budgeon CA
    31. Tijssen JGP
    32. Cornel JH
    33. Thompson PL

    (2020) Colchicine in patients with chronic coronary disease

    New England Journal of Medicine 31:2021372.

    https://doi.org/10.1056/NEJMoa2021372

    • Google Scholar
26. 1. Opstal TSJ
    2. Hoogeveen RM
    3. Fiolet ATL
    4. Silvis MJM
    5. The SHK
    6. Bax WA
    7. de Kleijn DPV
    8. Mosterd A
    9. Stroes ESG
    10. Cornel JH

    (2020) Colchicine attenuates inflammation beyond the inflammasome in chronic coronary artery disease: a LoDoCo2 proteomic substudy

    Circulation 381:50560.

    https://doi.org/10.1161/CIRCULATIONAHA.120.050560

    • Google Scholar
27. 1. Pen A
    2. Yam Y
    3. Chen L
    4. Dennie C
    5. McPherson R
    6. Chow BJ

    (2013) Discordance between framingham risk score and atherosclerotic plaque burden

    European Heart Journal 34:1075–1082.

    https://doi.org/10.1093/eurheartj/ehs473

    • PubMed
    • Google Scholar
28. 1. Pirro M
    2. Simental-Mendía LE
    3. Bianconi V
    4. Watts GF
    5. Banach M
    6. Sahebkar A

    (2019) Effect of statin therapy on arterial wall inflammation based on 18F-FDG PET/CT: a systematic review and Meta-Analysis of interventional studies

    Journal of Clinical Medicine 8:118.

    https://doi.org/10.3390/jcm8010118

    • PubMed
    • Google Scholar
29. 1. Ridker PM
    2. Everett BM
    3. Thuren T
    4. MacFadyen JG
    5. Chang WH
    6. Ballantyne C
    7. Fonseca F
    8. Nicolau J
    9. Koenig W
    10. Anker SD
    11. Kastelein JJP
    12. Cornel JH
    13. Pais P
    14. Pella D
    15. Genest J
    16. Cifkova R
    17. Lorenzatti A
    18. Forster T
    19. Kobalava Z
    20. Vida-Simiti L
    21. Flather M
    22. Shimokawa H
    23. Ogawa H
    24. Dellborg M
    25. Rossi PRF
    26. Troquay RPT
    27. Libby P
    28. Glynn RJ
    29. CANTOS Trial Group

    (2017) Antiinflammatory therapy with canakinumab for atherosclerotic disease

    New England Journal of Medicine 377:1119–1131.

    https://doi.org/10.1056/NEJMoa1707914

    • PubMed
    • Google Scholar
30. 1. Shirai T
    2. Nazarewicz RR
    3. Wallis BB
    4. Yanes RE
    5. Watanabe R
    6. Hilhorst M
    7. Tian L
    8. Harrison DG
    9. Giacomini JC
    10. Assimes TL
    11. Goronzy JJ
    12. Weyand CM

    (2016) The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease

    Journal of Experimental Medicine 213:337–354.

    https://doi.org/10.1084/jem.20150900

    • PubMed
    • Google Scholar
31. 1. Silvestre-Roig C
    2. Braster Q
    3. Ortega-Gomez A
    4. Soehnlein O

    (2020) Neutrophils as regulators of cardiovascular inflammation

    Nature Reviews Cardiology 17:327–340.

    https://doi.org/10.1038/s41569-019-0326-7

    • PubMed
    • Google Scholar
32. 1. Simmini S
    2. Bialecka M
    3. Huch M
    4. Kester L
    5. van de Wetering M
    6. Sato T
    7. Beck F
    8. van Oudenaarden A
    9. Clevers H
    10. Deschamps J

    (2014) Transformation of intestinal stem cells into gastric stem cells on loss of transcription factor Cdx2

    Nature Communications 5:5728.

    https://doi.org/10.1038/ncomms6728

    • PubMed
    • Google Scholar
33. 1. Takubo K
    2. Goda N
    3. Yamada W
    4. Iriuchishima H
    5. Ikeda E
    6. Kubota Y
    7. Shima H
    8. Johnson RS
    9. Hirao A
    10. Suematsu M
    11. Suda T

    (2010) Regulation of the HIF-1alpha level is essential for hematopoietic stem cells

    Cell Stem Cell 7:391–402.

    https://doi.org/10.1016/j.stem.2010.06.020

    • PubMed
    • Google Scholar
34. 1. Tardif JC
    2. Kouz S
    3. Waters DD
    4. Bertrand OF
    5. Diaz R
    6. Maggioni AP
    7. Pinto FJ
    8. Ibrahim R
    9. Gamra H
    10. Kiwan GS
    11. Berry C
    12. López-Sendón J
    13. Ostadal P
    14. Koenig W
    15. Angoulvant D
    16. Grégoire JC
    17. Lavoie MA
    18. Dubé MP
    19. Rhainds D
    20. Provencher M
    21. Blondeau L
    22. Orfanos A
    23. L'Allier PL
    24. Guertin MC
    25. Roubille F

    (2019) Efficacy and safety of Low-Dose colchicine after myocardial infarction

    New England Journal of Medicine 381:2497–2505.

    https://doi.org/10.1056/NEJMoa1912388

    • PubMed
    • Google Scholar
35. 1. Tarkin JM
    2. Joshi FR
    3. Rudd JH

    (2014) PET imaging of inflammation in atherosclerosis

    Nature Reviews Cardiology 11:443–457.

    https://doi.org/10.1038/nrcardio.2014.80

    • PubMed
    • Google Scholar
36. 1. Ter Horst R
    2. Jaeger M
    3. Smeekens SP
    4. Oosting M
    5. Swertz MA
    6. Li Y
    7. Kumar V
    8. Diavatopoulos DA
    9. Jansen AFM
    10. Lemmers H
    11. Toenhake-Dijkstra H
    12. van Herwaarden AE
    13. Janssen M
    14. van der Molen RG
    15. Joosten I
    16. Sweep F
    17. Smit JW
    18. Netea-Maier RT
    19. Koenders M
    20. Xavier RJ
    21. van der Meer JWM
    22. Dinarello CA
    23. Pavelka N
    24. Wijmenga C
    25. Notebaart RA
    26. Joosten LAB
    27. Netea MG

    (2016) Host and environmental factors influencing individual human cytokine responses

    Cell 167:1111–1124.

    https://doi.org/10.1016/j.cell.2016.10.018

    • PubMed
    • Google Scholar
37. 1. Tsou CL
    2. Peters W
    3. Si Y
    4. Slaymaker S
    5. Aslanian AM
    6. Weisberg SP
    7. Mack M
    8. Charo IF

    (2007) Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites

    Journal of Clinical Investigation 117:902–909.

    https://doi.org/10.1172/JCI29919

    • PubMed
    • Google Scholar
38. 1. van der Heijden CDCC
    2. Groh L
    3. Keating ST
    4. Kaffa C
    5. Noz MP
    6. Kersten S
    7. van Herwaarden AE
    8. Hoischen A
    9. Joosten LAB
    10. Timmers HJLM
    11. Netea MG
    12. Riksen NP

    (2020) Catecholamines induce trained immunity in monocytes in vitro and in vivo

    Circulation Research 127:269–283.

    https://doi.org/10.1161/CIRCRESAHA.119.315800

    • Google Scholar
39. 1. van der Valk FM
    2. Kuijk C
    3. Verweij SL
    4. Stiekema LCA
    5. Kaiser Y
    6. Zeerleder S
    7. Nahrendorf M
    8. Voermans C
    9. Stroes ESG

    (2016) Increased haematopoietic activity in patients with atherosclerosis

    European Heart Journal 15:425–432.

    https://doi.org/10.1093/eurheartj/ehw246

    • Google Scholar
40. 1. van Griethuysen JJM
    2. Fedorov A
    3. Parmar C
    4. Hosny A
    5. Aucoin N
    6. Narayan V
    7. Beets-Tan RGH
    8. Fillion-Robin JC
    9. Pieper S
    10. Aerts H

    (2017) Computational radiomics system to decode the radiographic phenotype

    Cancer Research 77:e104–e107.

    https://doi.org/10.1158/0008-5472.CAN-17-0339

    • PubMed
    • Google Scholar
41. 1. van Wijk DF
    2. Sjouke B
    3. Figueroa A
    4. Emami H
    5. van der Valk FM
    6. MacNabb MH
    7. Hemphill LC
    8. Schulte DM
    9. Koopman MG
    10. Lobatto ME
    11. Verberne HJ
    12. Fayad ZA
    13. Kastelein JJ
    14. Mulder WJ
    15. Hovingh GK
    16. Tawakol A
    17. Stroes ES

    (2014) Nonpharmacological lipoprotein apheresis reduces arterial inflammation in familial hypercholesterolemia

    Journal of the American College of Cardiology 64:1418–1426.

    https://doi.org/10.1016/j.jacc.2014.01.088

    • PubMed
    • Google Scholar
42. 1. Weber C
    2. Shantsila E
    3. Hristov M
    4. Caligiuri G
    5. Guzik T
    6. Heine GH
    7. Hoefer IE
    8. Monaco C
    9. Peter K
    10. Rainger E
    11. Siegbahn A
    12. Steffens S
    13. Wojta J
    14. Lip GY

    (2016) Role and analysis of monocyte subsets in cardiovascular disease. joint consensus document of the european society of cardiology (ESC) Working groups "Atherosclerosis & Vascular Biology" and "Thrombosis"

    Thrombosis and Haemostasis 116:626–637.

    https://doi.org/10.1160/TH16-02-0091

    • PubMed
    • Google Scholar
43. 1. Yu G
    2. Wang LG
    3. Han Y
    4. He QY

    (2012) clusterProfiler: an R package for comparing biological themes among gene clusters

    OMICS: A Journal of Integrative Biology 16:284–287.

    https://doi.org/10.1089/omi.2011.0118

    • PubMed
    • Google Scholar
44. 1. Yvan-Charvet L
    2. Pagler T
    3. Gautier EL
    4. Avagyan S
    5. Siry RL
    6. Han S
    7. Welch CL
    8. Wang N
    9. Randolph GJ
    10. Snoeck HW
    11. Tall AR

    (2010) ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation

    Science 328:1689–1693.

    https://doi.org/10.1126/science.1189731

    • PubMed
    • Google Scholar
45. 1. Ziegler-Heitbrock L
    2. Ancuta P
    3. Crowe S
    4. Dalod M
    5. Grau V
    6. Hart DN
    7. Leenen PJ
    8. Liu YJ
    9. MacPherson G
    10. Randolph GJ
    11. Scherberich J
    12. Schmitz J
    13. Shortman K
    14. Sozzani S
    15. Strobl H
    16. Zembala M
    17. Austyn JM
    18. Lutz MB

    (2010) Nomenclature of monocytes and dendritic cells in blood

    Blood 116:e74–e80.

    https://doi.org/10.1182/blood-2010-02-258558

    • PubMed
    • Google Scholar

Author details

1. Marlies P Noz

   Department of Internal Medicine and Radboud Institute for Molecular Life Science (RIMLS), Radboud University Medical Center, Nijmegen, Netherlands

   Contribution

   Data curation, Formal analysis, Investigation, Visualization, Writing - original draft, Project administration

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0002-2299-8313

2. Siroon Bekkering

   Department of Internal Medicine and Radboud Institute for Molecular Life Science (RIMLS), Radboud University Medical Center, Nijmegen, Netherlands

   Contribution

   Conceptualization, Formal analysis, Supervision, Writing - original draft, Writing - review and editing

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0003-1149-466X

3. Laszlo Groh

   Department of Internal Medicine and Radboud Institute for Molecular Life Science (RIMLS), Radboud University Medical Center, Nijmegen, Netherlands

   Contribution

   Formal analysis, Investigation, Writing - review and editing

   Competing interests

   No competing interests declared

4. Tim MJ Nielen

   Department of Cardiology, Canisius Wilhelmina Hospital, Nijmegen, Netherlands

   Contribution

   Formal analysis, Investigation, Writing - review and editing

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0001-7762-5912

5. Evert JP Lamfers

   Department of Cardiology, Canisius Wilhelmina Hospital, Nijmegen, Netherlands

   Contribution

   Formal analysis, Investigation, Writing - review and editing

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0002-5582-3720

6. Andreas Schlitzer

   Quantitative Systems Biology, Life & Medical Sciences Institute, University of Bonn, Single Cell Genomics and Epigenomics Unit at the German Center for Neurodegenerative Diseases and the University of Bonn, Bonn, Germany

   Contribution

   Formal analysis, Supervision, Writing - review and editing

   Competing interests

   No competing interests declared

7. Saloua El Messaoudi

   Department of Cardiology, Radboud University Medical Center, Nijmegen, Netherlands

   Contribution

   Investigation, Writing - review and editing

   Competing interests

   No competing interests declared

8. Niels van Royen

   Department of Cardiology, Radboud University Medical Center, Nijmegen, Netherlands

   Contribution

   Supervision, Investigation, Writing - review and editing

   Competing interests

   No competing interests declared

9. Erik HJPG Huys

   Department of Laboratory Medicine – Laboratory for Haematology, Radboud University Medical Center, Nijmegen, Netherlands

   Contribution

   Formal analysis, Investigation, Writing - review and editing

   Competing interests

   No competing interests declared

10. Frank WMB Preijers

    Department of Laboratory Medicine – Laboratory for Haematology, Radboud University Medical Center, Nijmegen, Netherlands

    Contribution

    Conceptualization, Formal analysis, Supervision, Writing - review and editing

    Competing interests

    No competing interests declared

11. Esther MM Smeets

    Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, Netherlands

    Contribution

    Data curation, Formal analysis, Writing - review and editing

    Competing interests

    No competing interests declared

12. Erik HJG Aarntzen

    Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, Netherlands

    Contribution

    Conceptualization, Supervision, Writing - review and editing

    Competing interests

    No competing interests declared

13. Bowen Zhang

    Department of Computational Biology for Individualised Infection Medicine, Centre for Individualised Infection Medicine (CiiM) & TWINCORE, joint ventures between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH), Hannover, Germany

    Contribution

    Data curation, Software, Formal analysis, Visualization, Writing - original draft, Writing - review and editing

    Competing interests

    No competing interests declared

14. Yang Li

    1. Department of Internal Medicine and Radboud Institute for Molecular Life Science (RIMLS), Radboud University Medical Center, Nijmegen, Netherlands
    2. Department of Computational Biology for Individualised Infection Medicine, Centre for Individualised Infection Medicine (CiiM) & TWINCORE, joint ventures between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH), Hannover, Germany

    Contribution

    Conceptualization, Data curation, Supervision, Methodology, Writing - review and editing

    Competing interests

    No competing interests declared

15. Manita EJ Bremmers

    Department of Haematology, Radboud University Medical Center, Nijmegen, Netherlands

    Contribution

    Investigation, Methodology, Writing - review and editing

    Competing interests

    No competing interests declared

16. Walter JFM van der Velden

    Department of Haematology, Radboud University Medical Center, Nijmegen, Netherlands

    Contribution

    Supervision, Methodology, Writing - review and editing

    Competing interests

    No competing interests declared

17. Harry Dolstra

    Department of Laboratory Medicine – Laboratory for Haematology, Radboud University Medical Center, Nijmegen, Netherlands

    Contribution

    Supervision, Methodology, Writing - review and editing

    Competing interests

    No competing interests declared

18. Leo AB Joosten

    1. Department of Internal Medicine and Radboud Institute for Molecular Life Science (RIMLS), Radboud University Medical Center, Nijmegen, Netherlands
    2. Department of Medical Genetics, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania

    Contribution

    Conceptualization, Supervision, Funding acquisition, Writing - review and editing

    Competing interests

    No competing interests declared

    "This ORCID iD identifies the author of this article:" 0000-0001-6166-9830

19. Marc E Gomes

    Department of Cardiology, Canisius Wilhelmina Hospital, Nijmegen, Netherlands

    Contribution

    Conceptualization, Supervision, Writing - review and editing

    Competing interests

    No competing interests declared

20. Mihai G Netea

    1. Department of Internal Medicine and Radboud Institute for Molecular Life Science (RIMLS), Radboud University Medical Center, Nijmegen, Netherlands
    2. Department for Genomics & Immunoregulation, Life and Medical Sciences Institute (LIMES), University of Bonn, Bonn, Germany

    Contribution

    Conceptualization, Supervision, Funding acquisition, Writing - review and editing

    Competing interests

    No competing interests declared

21. Niels P Riksen

    Department of Internal Medicine and Radboud Institute for Molecular Life Science (RIMLS), Radboud University Medical Center, Nijmegen, Netherlands

    Contribution

    Conceptualization, Resources, Supervision, Funding acquisition, Investigation, Methodology, Writing - original draft, Project administration, Writing - review and editing

    For correspondence

    niels.riksen@radboudumc.nl

    Competing interests

    No competing interests declared

    "This ORCID iD identifies the author of this article:" 0000-0001-9197-8124

• 2,043

  views

• 280

  downloads

• 31

  citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.